A nurse is assessing a client who has a cast in place for a fractured tibia. Which of the following actions should the nurse take first?

A. Use Echinacea to manage joint pain:
Echinacea is a natural supplement, but its effectiveness in managing joint pain related to osteoarthritis is not well-established. It's important for individuals to consult their healthcare provider before using any supplements, as they may interact with medications or have other adverse effects.

B. Maintain a recommended body weight.
Maintaining a healthy body weight is an important recommendation for managing osteoarthritis. Excess weight puts additional stress on weight-bearing joints, such as knees and hips, which can worsen osteoarthritis symptoms. Losing weight, if necessary, or maintaining a healthy weight can help reduce joint pain and improve mobility in individuals with osteoarthritis.

C. Apply ice to the joint before exercising:
Applying ice can help reduce inflammation and provide pain relief, but it's typically used after exercising or during acute flare-ups, not necessarily before exercising. Heat is often recommended before exercise to warm up the joint and improve flexibility.

D. Reduce the amount of purine in the diet:
This recommendation is more relevant for managing gout, a different type of arthritis caused by the buildup of uric acid crystals in the joints. Purine-rich foods can trigger gout attacks but are not directly related to osteoarthritis. Osteoarthritis is primarily related to wear and tear of the joints over time.

A. Increased urinary output: Phenazopyridine (Pyridium) does not directly impact urinary output. Its primary function is to provide relief from urinary pain, burning, and discomfort associated with urinary tract infections (UTIs) or other urinary conditions. It does not affect the amount of urine a person produces.

B. Decreased WBC's: Phenazopyridine does not directly influence white blood cell count (WBCs). WBC count is an indicator of the body's immune response and is typically used to assess the presence of infection. Phenazopyridine provides symptomatic relief but does not affect the underlying infection or the body's immune response to it.

C. Increased uric acid: Phenazopyridine does not affect uric acid levels. Uric acid is a waste product that is excreted by the kidneys. Elevated uric acid levels can be associated with conditions like gout, but Phenazopyridine does not have any direct impact on these levels.

D. Decreased bladder pain/spasms: Phenazopyridine is intended to relieve symptoms such as bladder pain, spasms, burning sensation, and discomfort experienced during urination. Therefore, the effectiveness of Phenazopyridine is indicated by a reduction in these symptoms. If the patient reports a decrease in bladder pain and spasms, it suggests that the medication is working to alleviate the discomfort associated with urinary tract issues.